Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just don’t play Relax by Frankie goes to Hollywood near any govt buildings while you are visiting.
Yep. The AS goes first to cover the warrants. DCTH reserves the right to RS through April 19, 2019.
Which, if you believe crazy me that this might...MIGHT...be a bluff, would provide poison pill air cover from April 7, 2018 (voting ends April 6, 2018) all the way through FDA approval.
Spooky.
Of course right now I am more stunned that I got circular Sam to write a post containing just a single word. I’m on the phone with Guinness right now to see if it’s a world record.
Uh huh. I thought you already sold after being decimated? And if not and you continue to hold DCTH shares, then well...welcome to the box of rocks club!
Oops. That was meant to be a PM.
We need to call Captain Underpants!
So can you do us all a favor? I will set up a message board and you and circular Sam can post whatever it is non DCTH shareholders talk about on a message board when they don’t own DCTH stock.
The latest filing looks like it was just swept under the rug
So? You think we’re just a box of rocks?
But I would not want to see you leave this pesky message board!!!
WHY DOES DCTH NEED A REVERSE SPLIT NOW? DCTH HAS MONEY TO KEEP THEM RUNNING THROUGH 10 MAY, 2018 WITHOUT TAPPING INTO ANY OF THE MONEY RECEIVED FROM THIS PLACEMENT.
DCTH should be fully funded through 10 August 2018 as a result of the February placement with ROTH.
From DCTH's FINAL PROSPECTUS, filed with the SEC and dated 9 FEB 2018:
Pending the uses described above, we intend to invest the net proceeds in interest-bearing investment-grade securities or deposits. The securities purchase agreement being entered into with certain purchasers in this offering limit our ability to raise capital both (i) for a set number of days, and (ii) for so long as warrants issued hereunder are outstanding, in any sort of variable priced financing. Even without receipt of proceeds from this offering, we have sufficient cash to operate for the next 90 days, and we do not intend to enter into any sort of variable priced financing in the future due to the highly dilutive nature of those financings.
But two weeks later their Schedule 14 states:
The Board of Directors believes that it is critical to the future viability of the Company that you vote “FOR” the Proposal. Failure to effect a reverse stock split will have a material adverse effect on the Company and its capital structure, including its ability to issue any common stock. We expect to need at least $20.0 million of cash to fund our operations and clinical trials for the remainder of 2018. Even with the net $4.65 million we just received from our follow on offering, it is unclear whether we will be able to continue as a going concern after May 31, 2018.
http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTEyMDg0NDA3JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTEyMDQxOTIxJkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
THE MESSAGING BY DCTH, SMH.
PR reads, in part:
“We are particularly pleased to be working with a supplier of Tillomed’s caliber and experience as it establishes firm control over our melphalan supply chain in Europe and, over time, will provide economies of scale,” noted Jennifer K. Simpson, Ph.D., MSN, CRNP President and CEO of Delcath. “As part of our strategic plan to further secure our commercial efforts in Europe, our supply agreement with Tillomed gives Delcath access to the drug dossier for melphalan hydrochloride. This is an important asset that potentially provides us with a drug approval pathway with the European Medicines Agency (EMA) for orphan diseases in Europe. As many of the cancers of the liver we are treating with CHEMOSAT are orphan indications in the United States, EMA drug approval for CHEMOSAT could potentially provide added market protection for these indications in Europe.”
ECONOMIES OF SCALE. Plural Noun. A proportionate saving in costs gained by an increased level of production.
DCTH needs more supply because they anticipate more demand. I pray they accurately convey this in the 10K's management discussion.
https://globenewswire.com/news-release/2018/03/07/1417545/0/en/Delcath-Announces-Commercial-Supply-Agreement-for-Melphalan-Hydrochloride-for-Injection-with-Tillomed-Laboratories.html
Once again, Sam...crickets. I have no idea what you are talking about.
Don’t you worry about the actual shareholders of DCTH, Captain Pump DCTH to Present Value $422.
I will vote no, I would rather Rome burn.
Plus, if BK is the call, I’d never have to read another Circular Sam post in my life. Almost worth torching the place myself!
Hahahaha. Wait, that’s our money. That’s not funny.
Honestly, at this point I should have bought a tuxedo, top hat and monocle, gone to Times Square and burn $100 bills.
Some gorilla-sized buys coming in and then ***POOF***
This has run way, way too smoothly to be a just few intrepid traders...
GRGRGRGGRRG
Could CDEL be capitulating? I’ve never seen that joker sport such a high share count. We’ll know soon enough.
How is this Legal?
I love this guy, lol! As i type this, we're about to face the devil's MMs. So either we move or we sputter in a controlled burn at $.015 all day.
GLTYA. I'll pop back in during "make the pain stop hour" later today.
That’s Captain present value $422, sir.
If you are long, I disagree.
LoL. It would have been something wonderful if they announced enrollment, earnings, update on NDA date.
I am not against a reverse split if it comes with an understanding that good news is in the pipeline and that it will come before or directly after (preferably before) a reverse split. We’re just getting too close not to put these topics on the table to update shareholders and to lift PPS in anticipation of CHEMSAT 2.0. This is happening in the next 12 months and they need to start driving that point home.
I would expect any smart management to do that, yet DCTH has not shown it has the capacity (at least to me) to make strategic moves. But DCTH didn’t even bother with a rearguard action that could have protected some portion of the PPS.
Yes, I appreciate today’s PR, but like all of them, you have to flesh out their ultimate meaning. In this instance, DCTH is increasing supply to meet demand—or anticipated demand—so why not just state this clearly?
Will today's release move PPS north? The long game in me says yes. This is a very good sign. But more problematic, near-term, are the @ssclown MM's. They are the worst case of herpes in recorded history, IMO. Karma for whoever directs these lap dogs.
Excellent news, thank you for sharing.
Ramping up supply to meet demand.
This is the kind of news we need. 10K out by COB 75 days from 12/31/17 per DCTH IR. That’s next Friday, folks.
Hmmmm. I may have to revisit a few theories. Still possible it is being done to thwart a black knight.
That said, Occam’s razor does appear to be getting sharper by the day...
Well, she won’t be getting my vote.
And your story changes by the minute. What the matter with you?
Yep. Mine just arrived via email from E*TRADE as well. We can vote online.
Where is the option to vote for a white knight or black knight?
I need a hero.
Why would it be bad for shareholders if she sold to the ‘Buffalo’ company?
Good lord this quickly devolving into a soap opera.
At least they subleased half the building.
After the 11/20 discussion, did someone try to send a letter to DCTH?
Something to watch for this time around for sure.
Tom had to buy time to move the goalpost.
After all, he PR’d $15-$24 million in revenue for Viking telecom during 2015-2016 that, POOF, never materialized.
WAFJ.
So where is DCTH going?
I’ll die if you say Buffalo. Say, what ever happened to Mikey?
Nope. They shut down a year or so ago. We’re all here in a therapeutic capacity for one another...
Post the link of whatever it
Is you are talking about. I don’t have a clue, but always interested in DCTH things.
Jenny, please announcing earnings soon.
Have a nice evening folks.
Your numbers, not mine, sir.
I just got taken to school.
Hell I’d settle for a social media presence and a PR from time
to time.
Not sure if the exec team is inept or if they’ve gone full Gollum on us, sitting in a dark cave, petting their patents and referring to CHEMSAT as ‘Precious’.
Uh huh. Something tells me when, not if, this moves north you’ll be right back into the game. If you ever left.
I judged you when you posted DCTH would hit (present value) $422/share.
But you can take heart, I’ve never looked at you from a perspective of being on a high horse. Shetland pony, possible.
Hahaha. I thought her name was pinky?